| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37.9M | — | -51.9% |
| Cost of Revenue | $33.6M | — | -39.9% |
| Gross Profit | $4.3M | — | -81.3% |
| R&D Expense | $2.7M | — | -37.1% |
| SG&A Expense | $15.3M | — | +17.3% |
| Operating Income | -$20.8M | — | +93.0% |
| Pre-tax Income | -$23.9M | — | +92.0% |
| Income Tax | -$253K | — | -123.5% |
| Net Income | -$23.7M | — | +92.1% |
| EPS (Basic) | -$0.29 | — | +92.1% |
| EPS (Diluted) | -$0.29 | — | +92.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $173.9M | +10.8% | -9.5% |
| Accounts Receivable | $36.4M | +3.3% | -52.9% |
| Inventory | $31.1M | -18.8% | -45.3% |
| Current Assets | $254.0M | +4.9% | -26.1% |
| Total Assets | $410.5M | +0.9% | -26.0% |
| Current Liabilities | $87.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $34.1M | — | +506.3% |
| Capital Expenditures | $1.4M | — | -89.5% |
| Investing Cash Flow | -$1.4M | — | +89.5% |
| Financing Cash Flow | -$15.8M | — | +26.6% |
| Free Cash Flow | $32.8M | — | +545.0% |
| +7.8% |
| Long-term Debt | $61.2M | -6.4% | -35.8% |
| Total Liabilities | $197.0M | +15.1% | -18.0% |
| Stockholders' Equity | $213.5M | -9.4% | -32.2% |